# EDGAR Filing Document

**Accession Number:** 0001499655
**File Stem:** 0001680359-23-000054
**Filing Date:** 2023-2
**Character Count:** 11412
**Document Hash:** ed620836f75db17ea699907108cfe465
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001680359-23-000054.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001680359-23-000054

**CONFORMED SUBMISSION TYPE**: 485BXT

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Precidian ETFs Trust
- **CENTRAL INDEX KEY:** 0001499655
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 485BXT
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22524
- **FILM NUMBER:** 23684222

**BUSINESS ADDRESS:**
- **STREET 1:** PRECIDIAN FUNDS LLC
- **STREET 2:** 350 MAIN STREET, SUITE 9
- **CITY:** BEDMINSTER
- **STATE:** NJ
- **ZIP:** 07921
- **BUSINESS PHONE:** 908-781-0560

**MAIL ADDRESS:**
- **STREET 1:** PRECIDIAN FUNDS LLC
- **STREET 2:** 350 MAIN STREET, SUITE 9
- **CITY:** BEDMINSTER
- **STATE:** NJ
- **ZIP:** 07921

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEXT ETFs Trust
- **DATE OF NAME CHANGE:** 20100820
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Precidian ETFs Trust
- **CENTRAL INDEX KEY:** 0001499655
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 485BXT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-171987
- **FILM NUMBER:** 23684221

**BUSINESS ADDRESS:**
- **STREET 1:** PRECIDIAN FUNDS LLC
- **STREET 2:** 350 MAIN STREET, SUITE 9
- **CITY:** BEDMINSTER
- **STATE:** NJ
- **ZIP:** 07921
- **BUSINESS PHONE:** 908-781-0560

**MAIL ADDRESS:**
- **STREET 1:** PRECIDIAN FUNDS LLC
- **STREET 2:** 350 MAIN STREET, SUITE 9
- **CITY:** BEDMINSTER
- **STATE:** NJ
- **ZIP:** 07921

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEXT ETFs Trust
- **DATE OF NAME CHANGE:** 20100820

## Series and Classes Contracts Data

### Anheuser-Busch InBev SA/NV ADRPLUS Fund (Series ID: S000058685)

| Class ID   | Class Name                              | Ticker Symbol   |
|:---|:---|:---|
| C000192667 | Anheuser-Busch InBev SA/NV ADRPLUS Fund |  |

### Novartis AG ADRPLUS Fund (Series ID: S000058686)

| Class ID   | Class Name               | Ticker Symbol   |
|:---|:---|:---|
| C000192668 | Novartis AG ADRPLUS Fund |  |

### Novo Nordisk A/S (B Shares) ADRPLUS Fund (Series ID: S000058687)

| Class ID   | Class Name                               | Ticker Symbol   |
|:---|:---|:---|
| C000192669 | Novo Nordisk A/S (B Shares) ADRPLUS Fund |  |

### Royal Dutch Shell plc (Class A) ADRPLUS Fund (Series ID: S000058689)

| Class ID   | Class Name                                   | Ticker Symbol   |
|:---|:---|:---|
| C000192671 | Royal Dutch Shell plc (Class A) ADRPLUS Fund |  |

### Royal Dutch Shell plc (Class B) ADRPLUS Fund (Series ID: S000058690)

| Class ID   | Class Name                                   | Ticker Symbol   |
|:---|:---|:---|
| C000192672 | Royal Dutch Shell plc (Class B) ADRPLUS Fund |  |

### Sanofi ADRPLUS Fund (Series ID: S000058691)

| Class ID   | Class Name          | Ticker Symbol   |
|:---|:---|:---|
| C000192673 | Sanofi ADRPLUS Fund |  |

### SAP AG ADRPLUS Fund (Series ID: S000058692)

| Class ID   | Class Name          | Ticker Symbol   |
|:---|:---|:---|
| C000192674 | SAP AG ADRPLUS Fund |  |

### Total S.A. ADRPLUS Fund (Series ID: S000058693)

| Class ID   | Class Name              | Ticker Symbol   |
|:---|:---|:---|
| C000192675 | Total S.A. ADRPLUS Fund |  |

### Toyota Motor Corporation ADRPLUS Fund (Series ID: S000058694)

| Class ID   | Class Name                            | Ticker Symbol   |
|:---|:---|:---|
| C000192676 | Toyota Motor Corporation ADRPLUS Fund |  |

### Vodafone Group Plc ADRPLUS Fund (Series ID: S000058695)

| Class ID   | Class Name                      | Ticker Symbol   |
|:---|:---|:---|
| C000192677 | Vodafone Group Plc ADRPLUS Fund |  |

### AstraZeneca PLC ADRPLUS Fund (Series ID: S000058696)

| Class ID   | Class Name                   | Ticker Symbol   |
|:---|:---|:---|
| C000192678 | AstraZeneca PLC ADRPLUS Fund |  |

### Banco Santander, S.A. ADRPLUS Fund (Series ID: S000058697)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000192679 | Banco Santander, S.A. ADRPLUS Fund |  |

### BP P.L.C. ADRPLUS Fund (Series ID: S000058698)

| Class ID   | Class Name             | Ticker Symbol   |
|:---|:---|:---|
| C000192680 | BP P.L.C. ADRPLUS Fund |  |

### British American Tobacco p.l.c. ADRPLUS Fund (Series ID: S000058699)

| Class ID   | Class Name                                   | Ticker Symbol   |
|:---|:---|:---|
| C000192681 | British American Tobacco p.l.c. ADRPLUS Fund |  |

### Diageo plc ADRPLUS Fund (Series ID: S000058700)

| Class ID   | Class Name              | Ticker Symbol   |
|:---|:---|:---|
| C000192682 | Diageo plc ADRPLUS Fund |  |

### GlaxoSmithKline plc ADRPLUS Fund (Series ID: S000058701)

| Class ID   | Class Name                       | Ticker Symbol   |
|:---|:---|:---|
| C000192683 | GlaxoSmithKline plc ADRPLUS Fund |  |

### HSBC Holdings Plc ADRPLUS Fund (Series ID: S000058702)

| Class ID   | Class Name                     | Ticker Symbol   |
|:---|:---|:---|
| C000192684 | HSBC Holdings Plc ADRPLUS Fund |  |

### Mitsubishi UFJ Financial Group, Inc. ADRPLUS Fund (Series ID: S000058703)

| Class ID   | Class Name                                        | Ticker Symbol   |
|:---|:---|:---|
| C000192685 | Mitsubishi UFJ Financial Group, Inc. ADRPLUS Fund |  |

As filed with the Securities and Exchange Commission on February 28, 2023<br>

Securities Act File No. 333-171987

Investment Company Act File No. 811-22524

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-1A

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 [X] <br> Pre-Effective Amendment No. <br> Post-Effective Amendment No. 150 [X]

and/or

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 [X] <br> Amendment No. 151 [X]

(Check appropriate box or boxes.)

**PRECIDIAN ETFs TRUST**<br>

------

(Exact Name of Registrant as Specified in Charter)

301 S. State Street, Suite N002

Newtown, PA 18940

------

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (908) 781-0560

Mark Criscitello

301 S. State Street, Suite N002

Newtown, PA 18940

------

(Name and Address of Agent for Service)

With copies to:

Michael W. Mundt, Esq.

Stradley Ronon Stevens & Young, LLP

2000 K Street, N.W.

Suite 700

Washington, DC 20006-1871 <br>

------

---

| | |
|:---|:---|
| Approximate Date of Proposed Public Offering: | Approximate Date of Proposed Public Offering: |
| It is proposed that this filing will become effective (check appropriate box): | It is proposed that this filing will become effective (check appropriate box): |
| [ ] | Immediately upon filing pursuant to paragraph (b) |
| [X] | On March 31, 2023 pursuant to paragraph (b) |
| [ ] | 60 days after filing pursuant to paragraph (a)(1) |
| [ ] | On (date) pursuant to paragraph (a)(1) |
| [ ] | 75 days after filing pursuant to paragraph (a)(2) |
| [ ] | On (date) pursuant to paragraph (a)(2) of rule 485. |
| If appropriate, check the following box: | If appropriate, check the following box: |
| [X] | this post-effective amendment designates a new effective date for a previously filed post-effective amendment.  |

---

------

#### EXPLANATORY NOTE

The sole purpose of this filing is to delay, until March 31, 2023, the effectiveness of the Registrant's Post-Effective Amendment No. 49 to its Registration Statement. Post-Effective Amendment No. 49 to the Registration Statement of Precidian ETFs Trust (the "Trust") relates solely to the Anheuser-Busch InBev SA/NV ADRPLUS Fund, AstraZeneca PLC ADRPLUS Fund, Banco Santander, S.A. ADRPLUS Fund, BP P.L.C. ADRPLUS Fund, British American Tobacco p.l.c. ADRPLUS Fund, Diageo plc ADRPLUS Fund, GlaxoSmithKline plc ADRPLUS Fund, HSBC Holdings Plc ADRPLUS Fund, Mitsubishi UFJ Financial Group, Inc. ADRPLUS Fund, Novartis AG ADRPLUS Fund, Novo Nordisk A/S (B Shares) ADRPLUS Fund, Royal Dutch Shell plc (Class A) ADRPLUS Fund, Royal Dutch Shell plc (Class B) ADRPLUS Fund, Sanofi ADRPLUS Fund, SAP AG ADRPLUS Fund, Total S.A. ADRPLUS Fund, Toyota Motor Corporation ADRPLUS Fund and Vodafone Group Plc ADRPLUS Fund. [Parts A and B of the Registrant's Post-Effective Amendment No. 72](http://www.sec.gov/Archives/edgar/data/1499655/000168028918000110/20180531precidian485bxt.htm), filed on June 1, 2018, are incorporated herein by reference. [Part C of the Registrant's Post-Effective Amendment No. 49](http://www.sec.gov/Archives/edgar/data/1499655/000168028917000182/20170614precidian485apos.htm), filed on June 14, 2017, is incorporated herein by reference.

The prospectus and statement of additional information for the other series of the Trust are not changed by the filing of this Post-Effective Amendment.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, Registrant certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) under the Securities Act and has duly caused this Amended Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Newtown and State of Pennsylvania on the 28<sup>th</sup> day of February 2023.

---

| | |
|:---|:---|
| PRECIDIAN ETFS TRUST | PRECIDIAN ETFS TRUST |
| By: | <u>/s/ Daniel J. McCabe&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> <br>Daniel J. McCabe<br> President |

---

Pursuant to the requirements of the Securities Act of 1933, this amendment to the Registration Statement has been signed below by the following person in the capacities and on the date indicated.

---

| | | |
|:---|:---|:---|
| **<u>Name</u>** | **<u>Title</u>** | **<u>Date</u>** |
| /s/ Mark S. Criscitello  | Trustee | February 28, 2023<br>|
| Mark S. Criscitello |  |  |
| \*  | Trustee | February 28, 2023 |
| John V. Sinon |  |  |
| \*  | Trustee | February 28, 2023 |
| Dennis J. DeCore |  |  |
| /s/ Daniel J. McCabe  | President | February 28, 2023 |
| Daniel J. McCabe | (Principal Executive Officer) |  |
| /s/ Joshua Hunter  | Chief Financial Officer and Treasurer | February 28, 2023 |
| Joshua Hunter | (Principal Financial Officer) |  |

---

---

| | |
|:---|:---|
| \*By: | /s/ Daniel J. McCabe |
|  | Daniel J. McCabe |
|  | Attorney in fact |

---

\* An original power of attorney authorizing Mark S. Criscitello, Daniel J. McCabe and Stuart Thomas to execute this registration statement and amendments thereto, for each of the trustees of the Registrant on whose behalf this registration statement is filed, is incorporated by reference [from the initial Registration Statement](http://www.sec.gov/Archives/edgar/data/1499655/000095012311058735/y04872exv99w1.htm) filed on June 13, 2011 and [from Post-Effective Amendment No. 10 to the Registration Statement](http://www.sec.gov/Archives/edgar/data/1499655/000114420414045424/v384396_ex99-other.htm) filed on July 29, 2014.